Given that IgA+ MBC were recently reported to be increased in the CNS of MS patients and displayed specificity against commensal micro-organisms in the intestines (17), an association was investigated between the abundance or phenotype of circulating IgA+ B cells, and serum levels of SCFAs (18). This evidence concerns the gene CD79A and myeloid sarcoma.